Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion...
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
About this item
Full title
Author / Creator
Xia, Shuai , Liu, Meiqin , Wang, Chao , Xu, Wei , Lan, Qiaoshuai , Feng, Siliang , Qi, Feifei , Bao, Linlin , Du, Lanying , Liu, Shuwen , Qin, Chuan , Sun, Fei , Shi, Zhengli , Zhu, Yun , Jiang, Shibo and Lu, Lu
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
The recent outbreak of coronavirus disease (COVID-19) caused by SARS-CoV-2 infection in Wuhan, China has posed a serious threat to global public health. To develop specific anti-coronavirus therapeutics and prophylactics, the molecular mechanism that underlies viral infection must first be defined. Therefore, we herein established a SARS-CoV-2 spik...
Alternative Titles
Full title
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7104723
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7104723
Other Identifiers
ISSN
1001-0602,1748-7838
E-ISSN
1748-7838
DOI
10.1038/s41422-020-0305-x
